NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Non-Current Debt (2019 - 2026)

NextPlat's (NXPL) quarterly Non-Current Debt came in at $1.0 million in Q2 2026, down 13.15% year-over-year from $1.2 million in Q2 2025, and down 12.77% quarter-over-quarter from $1.2 million in Q1 2026.

Analysis

NextPlat (NXPL) Non-Current Debt (2019 - 2026) Analysis & Trends

NextPlat (NXPL) has reported Non-Current Debt for 8 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non-Current Debt fell 13.15% year-over-year to $1.0 million in Q2 2026; TTM through Jun 2026 was $1.0 million, a 13.15% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, down 8.5% from the prior year.
  • Non-Current Debt was $1.0 million for Q2 2026 at NextPlat, down from $1.2 million in the prior quarter.
  • Over five years, Non-Current Debt peaked at $1.6 million in Q3 2023 and troughed at $131607.0 in Q2 2023.
  • A 5-year average of $940935.1 and a median of $1.2 million in 2025 frame the typical range for Non-Current Debt.
  • Across the five-year window, Non-Current Debt tumbled 41.18% in 2022 and surged 936.01% in 2023, its largest moves.
  • Over 5 years, Non-Current Debt stood at $216000.0 in 2022, then jumped by 605.09% to $1.5 million in 2023, then declined by 7.29% to $1.4 million in 2024, then retreated by 8.5% to $1.3 million in 2025, then retreated by 22.29% to $1.0 million in 2026.
  • The last three Non-Current Debt figures came in at $1.0 million (Q2 2026), $1.2 million (Q1 2026), and $1.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 12.09 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 11.61 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 150.67 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 2.57 Bn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 20.74 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 280.16 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn 1.26 Bn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 609.56 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn -
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.00 Mn
Mar 31, 2026 1.15 Mn
Dec 31, 2025 1.29 Mn
Sep 30, 2025 1.16 Mn
Jun 30, 2025 1.16 Mn
Mar 31, 2025 1.28 Mn
Dec 31, 2024 1.41 Mn
Sep 30, 2024 1.54 Mn
Jun 30, 2024 1.33 Mn
Mar 31, 2024 1.40 Mn
Dec 31, 2023 1.52 Mn
Sep 30, 2023 1.64 Mn
Jun 30, 2023 131,607.00
Mar 31, 2023 144,293.00
Dec 31, 2022 216,000.00
Sep 30, 2022 157,958.00
Jun 30, 2022 187,544.00
Mar 31, 2022 218,967.00
Dec 31, 2021 253,757.00
Sep 30, 2021 268,528.00